DessertStorms , 6 hours ago (edited 6 hours ago)

I understand they need to recoup research costs, but…

Except they don’t even need to do that, because, as is with most pharmaceuticals, the research was almost fully funded by the taxpayer.

And the 30% profit is for a generic product, so the research has already been done.

So yeah, 30% profit is of course much better than 3000%, but both are still obscene profiteering off of a lifesaving product paid for by, and then essentially withheld for ransom from, the general public.